![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Celsion Scores Patent for Delivery System
Celsion Scores Patent for Delivery System
Celsion received U.S. patent protection covering its lung-specific delivery system, TheraSilence.
The patent covers TheraSilence compositions and delivery forms in a range of therapeutic RNA entities.
“Our strategy is to seek to maximize the value of this platform in the near-term by pursuing collaborations and development agreements, while focusing internal development efforts on our two clinical stage candidates, ThermoDox and GEN-1, our DNA-based immunotherapy for the localized treatment of ovarian cancer,” Michael Targundo, chairman, president and CEO of Celsion, said in a prepared statement. — Anisa Jibrell
Upcoming Events
-
21Oct